The widespread adoption of GLP-1 weight-loss medications across South America has triggered a specific clinical need for "facial rescue" treatments.

As patients lose significant weight rapidly, the subcutaneous fat pads in the face—particularly the medial and lateral cheek pads—atrophy, leading to a gaunt, aged appearance. In response, 2026 has seen a record demand for high-viscosity Hyaluronic Acid (HA) fillers and autologous fat grafting to restore mid-face volume.

Clinics in Bogotá and Buenos Aires have developed specialized "Volume Restoration Protocols" specifically for post-GLP-1 patients. These protocols often involve a layered technique: deep placement of high-G-Prime fillers on the bone (supraperiosteal) to mimic skeletal support, followed by superficial "skin boosters" to treat the resulting skin laxity. This trend has not only increased the volume of filler sold but has also shifted the demographic toward male patients, who are using these medications in high numbers and seeking discreet facial restoration.